Evidence map›Paper›PMID 41497233›Full record

ReviewFrontiers in neurology2025

Breaking the learned helplessness paradigm in chronic stroke: an intensive neuroplasticity framework bridging European technology and African innovation.

Ibrahim Npochinto Moumeni

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ibrahim Npochinto MoumeniDepartment of Physiotherapy and Physical Medicine, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Most chronic stroke survivors develop learned helplessness regarding motor recovery prospects, accepting permanent disability despite evidence that neuroplasticity windows remain accessible years post-stroke. This review examines how intensive protocols targeting learned helplessness can achieve meaningful recovery across diverse healthcare settings. Methods: Comprehensive literature review using PubMed, Scopus, and specialized databases (1990-2024). Analysis included constraint-induced movement therapy protocols, progressive muscle lengthening techniques, and neuroplasticity principles across European high-technology centers and African human-intensive programs. Search incorporated systematic analysis of therapeutic intensity parameters, cultural adaptation protocols, and cross-continental implementation strategies. Results: Literature synthesis reveals meaningful functional recovery 2-5 years post-stroke when intensive protocols directly challenge learned helplessness through forced-use approaches, training intensities exceeding traditional therapy doses (3-6 h daily versus 30-45 min), and systematic addressing of secondary muscle adaptations. Cross-continental validation demonstrates equivalent outcomes between European technology-dependent and African human-intensive approaches when therapeutic intensity and neuroplasticity targeting remain consistent. Conclusion: Neuroplasticity-driven intensive rehabilitation can overcome learned helplessness and achieve meaningful motor recovery years after stroke without requiring expensive technology. Success depends on abandoning traditional recovery timelines, implementing culturally-adapted intensive protocols, and recognizing human expertise as the most powerful rehabilitation tool when properly applied.

Indexed as

constraint-induced movement therapycultural adaptationlearned helplessnessneuroplasticityresource-limited settingsstroke rehabilitation

Identifiers

PMID41497233
PMCPMC12767502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.